Official registry condition

Generalized Myasthenia Gravis peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Generalized Myasthenia Gravis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

1 profiles.

Registry update years

2026–2026 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles1

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases2

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 11 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Generalized Myasthenia Gravis unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT06055959

PeptideScanner retained ClinicalTrials.gov record NCT06055959 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
November 5, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06435312

PeptideScanner retained ClinicalTrials.gov record NCT06435312 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
October 2, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06471361

PeptideScanner retained ClinicalTrials.gov record NCT06471361 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
March 27, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →